Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3960 results

Sort By:

A Study of LUCAR-G79 in Subjects With Relapsed/Refractory Autoimmune Diseases

Study ID: NCT07049081
Start Date: 2025-07-31
End Date: 2030-04-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

42

Intervention / Treatment

LUCAR-G79 T cells

Sponsor

Nanjing Legend Biotech Co.

Source: clinicaltrials.gov

Share:
Add to list

A Single Arm Intervention Study to Assess the Acceptability, Tolerance and Ease of Use of Wilbo's Blends+ (Commercial Enteral Feed Based on Real Food) When Used as Part of a Dietitian Prescribed Enteral Feeding Plan

Study ID: NCT07036081
Start Date: 2025-09-01
End Date: 2026-03-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment
Sponsor

Nottingham University Hospitals NHS Trust

Source: clinicaltrials.gov

Share:
Add to list

Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea

Study ID: NCT06998095
Start Date: 2025-11-30
End Date: 2029-10-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment
Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis

Study ID: NCT06228781
Start Date: 2026-12-01
End Date: 2029-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Autologous haemopoietic stem cell transplantation

Sponsor

Tianjin Medical University General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Screening and Support for Youth (SASY)

Study ID: NCT06419595
Start Date: 2026-11-01
End Date: 2028-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

220

Intervention / Treatment

Behavioral: Screening and Support for Youth (SASY) Multi-component Platform: includes screening, feedback, single session intervention, and resource information

Behavioral: Screening and Support for Youth (SASY) Multi-component Platform: includes screening, feedback, single session intervention, and resource information

Sponsor

Cambridge Health Alliance

Source: clinicaltrials.gov

Share:
Add to list

Spiritual Needs of European Patients With Inflammatory Bowel Disease and Their Caregivers

Study ID: NCT07020481
Start Date: 2025-09
End Date: 2025-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment
Sponsor

University of Padova

Source: clinicaltrials.gov

Share:
Add to list

Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use Disorder

Study ID: NCT06559995
Start Date: 2025-08-01
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

30

Intervention / Treatment

ketone supplement "D-beta-hydroxybutryric acid and R-1,3 butanediol" 12g of ketones,

magnetic resonance imaging session

Placebo beverage

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list

Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients

Study ID: NCT06397781
Start Date: 2025-12
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

100

Intervention / Treatment

Skin Cleanser Combination No.1

Sponsor

Boston Children's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Phenotypes Associated With Constitutional EGFR Pathogenic Variants

Study ID: NCT06562491
Start Date: 2025-09
End Date: 2025-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment
Sponsor

Public assistance - Paris hospitals

Source: clinicaltrials.gov

Share:
Add to list

Imaging of Solid Tumors Using DLL3 SPECT

Study ID: NCT07052760
Start Date: 2025-07-31
End Date: 2027-08-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

45

Intervention / Treatment

111In-ABD147

Single-photon emission computed tomography (SPECT)/Computerized tomography (CT)

Sponsor

Thomas Hope

Source: clinicaltrials.gov

Share:
Add to list